{
  "id": "13-1837442",
  "ein": "13-1837442",
  "name": "Cancer Research Institute",
  "tier": "rich",
  "mission": "The Clinical Innovator provides funding for clinician-scientists aiming to launch innovative phase I/II or phase II clinical studies using novel immunotherapies.",
  "programs": [
    "CRI Irvington Postdoctoral Fellowships",
    "William B. Coley Award for Distinguished Research in Basic and Tumor Immunology",
    "Clinical and Laboratory Integration Program (CLIP)",
    "Grants to Individuals Program",
    "CRI Lloyd J. Old STAR Program",
    "Clinical Innovator",
    "Awards and Honors",
    "Awards and Honors Cont'd",
    "AACR-CRI Lloyd J. Old Award in Cancer Immunology",
    "CRI Irvington Postdoctoral Fellowship Program",
    "Clinic and Laboratory Integration Program (CLIP)",
    "Clinical Accelerator",
    "Grants and Patient Support"
  ],
  "geographicCoverage": [],
  "category": null,
  "website": "http://WWW.CANCERRESEARCH.ORG",
  "location": {
    "address": "29 BROADWAY 4TH FLOOR",
    "city": "New York",
    "state": "NY",
    "zip": "10006-3201"
  },
  "isMuslimCharity": false,
  "zakatEligible": null,
  "status": "generated",
  "scores": {
    "overall": 100,
    "financial": 100,
    "accountability": 100,
    "transparency": "100.00"
  },
  "awards": {
    "cnBeacons": [
      "4-Star Rating"
    ],
    "cnUrl": "https://www.charitynavigator.org/ein/131837442",
    "candidSeal": "Platinum",
    "candidUrl": "https://app.candid.org/profile/6906390",
    "bbbStatus": null,
    "bbbReviewUrl": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301"
  },
  "financials": {
    "totalRevenue": 32295259,
    "totalExpenses": 38552663,
    "programExpenses": 26628724,
    "adminExpenses": 2746561,
    "fundraisingExpenses": 3445611,
    "programExpenseRatio": "0.8398",
    "totalAssets": 138008864,
    "totalLiabilities": 70013010,
    "netAssets": 67995854
  },
  "baselineGovernance": null,
  "targeting": {
    "populationsServed": [
      "Men"
    ],
    "geographicCoverage": [
      "Global",
      "United States"
    ]
  },
  "trustSignals": {
    "hasAnnualReport": null,
    "hasAuditedFinancials": 1,
    "candidSeal": "platinum",
    "isConflictZone": 0,
    "nonprofitSizeTier": "large_nonprofit",
    "employeesCount": null,
    "volunteersCount": null
  },
  "websiteEvidenceSignals": {
    "claims_longitudinal": false,
    "claims_rcts": false,
    "claims_third_party_eval": true,
    "disclosure_richness": 2,
    "reports_annual_report": false,
    "reports_board_info": false,
    "reports_methodology": true,
    "reports_outcome_metrics": true
  },
  "lastUpdated": "2026-02-07 00:39:23",
  "sourceAttribution": {
    "admin_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-04T23:31:35",
      "value": 2746561
    },
    "candid_seal": {
      "source_name": "Candid",
      "source_url": "https://app.candid.org/profile/6906390",
      "timestamp": "2026-02-04T23:31:35",
      "value": "platinum"
    },
    "charity_navigator_score": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#ratings",
      "timestamp": "2026-02-04T23:31:35",
      "value": 100
    },
    "claims_zakat_eligible": {
      "source_name": "Charity Website",
      "source_url": "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGa0-R8GcTSpzy2R_Bm9e5QA5wQyjsG1wdQrxF9KfdIjSLFFUGZ5O3iMWvLdNcKN-hIvWYYrwzkPjAEBHRXz6e2SKzKFad43ohjvltT6opVB3EVIr-TdwqdryCYkg1W7yWCWzk=",
      "timestamp": "2026-01-25T20:35:54",
      "value": false
    },
    "founded_year": {
      "source_name": "Charity Website",
      "source_url": null,
      "timestamp": "2026-01-25T20:35:54",
      "value": 1953
    },
    "fundraising_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-04T23:31:35",
      "value": 3445611
    },
    "has_audited_financials": {
      "source_name": "Charity Website",
      "source_url": "http://WWW.CANCERRESEARCH.ORG",
      "timestamp": "2026-01-25T20:35:54",
      "value": true
    },
    "ntee_code": {
      "source_name": "ProPublica Form 990",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-04T23:31:35",
      "value": "H300"
    },
    "program_expense_ratio": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-04T23:31:35",
      "value": 0.8398
    },
    "program_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-04T23:31:35",
      "value": 26628724
    },
    "total_revenue": {
      "source_name": "Form 990 (2023)",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-04T23:31:35",
      "value": 32295259
    },
    "transparency_score": {
      "source_name": "Candid Platinum Seal",
      "source_url": "https://app.candid.org/profile/6906390",
      "timestamp": "2026-02-04T23:31:35",
      "value": 100
    },
    "working_capital_months": {
      "derived_from": [
        "total_assets",
        "total_liabilities",
        "total_expenses"
      ],
      "source_name": "Calculated from Form 990",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-04T23:31:35",
      "value": 21.2
    }
  },
  "primaryCategory": "MEDICAL_HEALTH",
  "categoryMetadata": {
    "importance": "HIGH",
    "neglectedness": "MEDIUM"
  },
  "causeTags": [
    "grantmaking",
    "international",
    "medical",
    "research",
    "usa"
  ],
  "programFocusTags": [
    "research-policy",
    "education-higher"
  ],
  "hideFromCurated": true,
  "theoryOfChange": "The Cancer Research Institute (CRI) has a published 'People x Biology x Data' strategy, which is described as an 'innovative framework' in their 2024 Impact Report. This framework emphasizes the integration of bioinformatics, artificial intelligence (AI), and machine learning to advance cancer immunotherapy. The approach aims to enhance researchers' ability to analyze complex biological data, identify novel biomarkers, and develop personalized treatment strategies, thereby accelerating discovery and ensuring new insights are translated into effective therapies for patients. This strategy is central to CRI's approach to achieving impact, fostering collaboration, deepening the understanding of the immune system, and leveraging data to bring treatments to patients faster.",
  "grantsData": [
    {
      "amount": 67700,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "237156071",
      "recipient_name": "FRED HUTCHINSON CANCER RESEARCH CENTER",
      "region": null
    },
    {
      "amount": 20942,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "205744808",
      "recipient_name": "FOCUSED ULTRASOUND FOUNDATION",
      "region": null
    },
    {
      "amount": 729000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131624158",
      "recipient_name": "THE ROCKEFELLER UNIVERSITY",
      "region": null
    },
    {
      "amount": 1132000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131624182",
      "recipient_name": "MEMORIAL SLOAN KETTERING CANCER CENTER",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "162425500",
      "recipient_name": "ALBERT EINSTEIN COLLEGE OF MEDICINE",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131623978",
      "recipient_name": "WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "136171197",
      "recipient_name": "ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI",
      "region": null
    },
    {
      "amount": 25000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "236251648",
      "recipient_name": "AMERICAN ASSOCIATION FOR CANCER RESEARCH",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "580566256",
      "recipient_name": "EMORY UNIVERSITY",
      "region": null
    },
    {
      "amount": 1015000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "746001118",
      "recipient_name": "THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER",
      "region": null
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "123720366",
      "recipient_name": "THE J DAVID GLADSTONE INSTITUTES",
      "region": null
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "163600539",
      "recipient_name": "UNIVERSITY OF ALABAMA AT BIRMINGHAM",
      "region": null
    },
    {
      "amount": 160000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "916001537",
      "recipient_name": "UNIVERSITY OF WASHINGTON",
      "region": null
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "316025986",
      "recipient_name": "OHIO STATE UNIVERSITY",
      "region": null
    },
    {
      "amount": 299786,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "430654872",
      "recipient_name": "SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE",
      "region": null
    },
    {
      "amount": 729000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "941156365",
      "recipient_name": "STANFORD UNIVERSITY",
      "region": null
    },
    {
      "amount": 1039700,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042774441",
      "recipient_name": "BOSTON CHILDREN'S HOSPITAL",
      "region": null
    },
    {
      "amount": 1793000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "231352685",
      "recipient_name": "UNIVERSITY OF PENNSYLVANIA",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "520858115",
      "recipient_name": "NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "263428781",
      "recipient_name": "BROAD INSTITUTE OF MIT AND HARVARD",
      "region": null
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "883838475",
      "recipient_name": "OVERT",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042263040",
      "recipient_name": "DANA-FARBER CANCER INSTITUTE INC",
      "region": null
    },
    {
      "amount": 1243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "946036493",
      "recipient_name": "UNIVERSITY OF CALIFORNIA SAN FRANCISCO",
      "region": null
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "041564655",
      "recipient_name": "MASSACHUSETTS GENERAL HOSPITAL",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "043167352",
      "recipient_name": "UNIVERSITY OF MASSACHUSETTS CHAN MEDICAL SCHOOL",
      "region": null
    },
    {
      "amount": 543000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "135562309",
      "recipient_name": "NEW YORK UNIVERSITY MEDICAL CENTER",
      "region": null
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "136217139",
      "recipient_name": "UNIVERSITY OF CHICAGO MEDICAL CENTER",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "430653611",
      "recipient_name": "WASHINGTON UNIVERSITY SCHOOL OF MEDICINE",
      "region": null
    },
    {
      "amount": 1250000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "135598093",
      "recipient_name": "COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK",
      "region": null
    },
    {
      "amount": 6361,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042312909",
      "recipient_name": "THE BRIGHAM AND WOMEN'S HOSPITAL INC",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "330328688",
      "recipient_name": "THE LA JOLLA INSTITUTE FOR IMMUNOLOGY",
      "region": null
    },
    {
      "amount": 1550000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "060646973",
      "recipient_name": "YALE UNIVERSITY SCHOOL OF MEDICINE",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "210634501",
      "recipient_name": "PRINCETON UNIVERSITY",
      "region": null
    },
    {
      "amount": 1250000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EAST ASIA AND THE PACIFIC"
    },
    {
      "amount": 243000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA"
    },
    {
      "amount": 57794,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA"
    },
    {
      "amount": 2269338,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA"
    },
    {
      "amount": 243000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 90000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 200000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 1250000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 196626,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)"
    },
    {
      "amount": 979640,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)"
    },
    {
      "amount": 199974,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)"
    }
  ],
  "evaluationTrack": "RESEARCH_POLICY",
  "foundedYear": 1953,
  "form990Exempt": 0,
  "form990ExemptReason": "",
  "noFilings": false,
  "amalEvaluation": {
    "charity_ein": "13-1837442",
    "charity_name": "Cancer Research Institute",
    "amal_score": 65,
    "wallet_tag": "SADAQAH-ELIGIBLE",
    "evaluation_date": "2026-01-25 20:36:57",
    "rubric_version": "4.0.0",
    "confidence_scores": {
      "alignment": 27,
      "data_confidence": 1,
      "impact": 38
    },
    "score_details": {
      "alignment": {
        "cause_urgency_label": "GLOBAL_HEALTH",
        "components": [
          {
            "evidence": "Asnaf: fi_sabilillah (+5)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Muslim Donor Fit",
            "possible": 19,
            "scored": 5,
            "status": "partial"
          },
          {
            "evidence": "Cause area: Global Health (13/13)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Cause Urgency",
            "possible": 13,
            "scored": 13,
            "status": "full"
          },
          {
            "evidence": "Well-covered space with mainstream reach",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Underserved Space",
            "possible": 7,
            "scored": 0,
            "status": "partial"
          },
          {
            "evidence": "Founded 1953 (73 years \u2014 6/6)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Track Record",
            "possible": 6,
            "scored": 6,
            "status": "full"
          },
          {
            "evidence": "Revenue: $32.3M (3/5 funding gap)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Funding Gap",
            "possible": 5,
            "scored": 3,
            "status": "full"
          }
        ],
        "muslim_donor_fit_level": "LOW",
        "rationale": "Alignment 27/50: LOW Muslim donor fit, global health cause area",
        "score": 27
      },
      "data_confidence": {
        "badge": "HIGH",
        "data_quality_label": "HIGH",
        "data_quality_value": 1,
        "overall": 1,
        "transparency_label": "PLATINUM",
        "transparency_value": 1,
        "verification_tier": "HIGH",
        "verification_value": 1
      },
      "impact": {
        "components": [
          {
            "evidence": "$2.96/beneficiary (exceptional for GLOBAL_HEALTH)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Cost Per Beneficiary",
            "possible": 20,
            "scored": 20,
            "status": "full"
          },
          {
            "evidence": "Delivery model: Systemic Change",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Directness",
            "possible": 7,
            "scored": 2,
            "status": "full"
          },
          {
            "evidence": "Working capital: 21.2 months (EXCESSIVE)",
            "improvement_suggestion": "Build working capital reserves to 1-3 months of operating expenses",
            "improvement_value": 4,
            "name": "Financial Health",
            "possible": 7,
            "scored": 0,
            "status": "full"
          },
          {
            "evidence": "Program expense ratio: 84%",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Program Ratio",
            "possible": 6,
            "scored": 6,
            "status": "full"
          },
          {
            "evidence": "Evidence & outcomes: VERIFIED",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Evidence & Outcomes",
            "possible": 5,
            "scored": 5,
            "status": "full"
          },
          {
            "evidence": "Theory of change: STRONG",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Theory of Change",
            "possible": 3,
            "scored": 3,
            "status": "full"
          },
          {
            "evidence": "Board governance: STRONG (34 members)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Governance",
            "possible": 2,
            "scored": 2,
            "status": "full"
          }
        ],
        "cost_per_beneficiary": 2.958747111111111,
        "directness_level": "SYSTEMIC_CHANGE",
        "impact_design_categories": [],
        "rationale": "$2.96/beneficiary; Delivery: systemic change; Impact 38/50",
        "score": 38
      },
      "judge_issues": [
        {
          "field": "propublica.expense_ratio",
          "judge": "crawl_quality",
          "message": "Expenses ($38,552,663) exceed revenue ($32,295,259) by 19%",
          "severity": "warning"
        },
        {
          "field": "charity_navigator.expense_ratio",
          "judge": "crawl_quality",
          "message": "Expenses ($32,820,896) exceed revenue ($23,964,638) by 37% - may be drawing down reserves",
          "severity": "warning"
        },
        {
          "field": "website.ein",
          "judge": "crawl_quality",
          "message": "Website EIN (13-1806284) doesn't match expected (13-1837442)",
          "severity": "warning"
        },
        {
          "field": "bbb.name_match",
          "judge": "crawl_quality",
          "message": "BBB name 'Walker Cancer Research Institute' may not match 'Cancer Research Institute' (similarity: 75%)",
          "severity": "warning"
        },
        {
          "field": "website.website_profile.ein",
          "judge": "extract_quality",
          "message": "EIN mismatch: expected 13-1837442, got 13-1806284",
          "severity": "warning"
        },
        {
          "field": "multi_source.ein_consistency",
          "judge": "extract_quality",
          "message": "Multiple different EINs found across sources: {'131837442', '131806284'}",
          "severity": "warning"
        },
        {
          "field": "discovered.evaluations.confidence",
          "judge": "discover_quality",
          "message": "Low confidence (0.00) for evaluations discovery (threshold: 0.75)",
          "severity": "info"
        },
        {
          "field": "discovered.theory_of_change.confidence",
          "judge": "discover_quality",
          "message": "Low confidence (0.00) for theory_of_change discovery (threshold: 0.75)",
          "severity": "info"
        },
        {
          "field": "discovered.awards.confidence",
          "judge": "discover_quality",
          "message": "Low confidence (0.00) for awards discovery (threshold: 0.75)",
          "severity": "info"
        },
        {
          "field": "discovered.evaluations.evaluators[3].url",
          "judge": "discover_quality",
          "message": "Evaluation source domain 'charitywatch.org' is not a known trusted evaluator",
          "severity": "info"
        },
        {
          "field": "discovered.theory_of_change",
          "judge": "discover_quality",
          "message": "Theory of change URL found but description not extracted",
          "severity": "info"
        },
        {
          "field": "hallucination_denylist.populations_served",
          "judge": "synthesize_quality",
          "message": "Hallucination-prone field 'populations_served' lacks cross-source corroboration",
          "severity": "warning"
        },
        {
          "field": "hallucination_denylist.third_party_evaluated",
          "judge": "synthesize_quality",
          "message": "Hallucination-prone field 'third_party_evaluated' lacks cross-source corroboration",
          "severity": "warning"
        }
      ],
      "risk_deduction": 0,
      "risks": {
        "overall_risk_level": "LOW",
        "risk_summary": "No significant risks identified.",
        "risks": [],
        "total_deduction": 0
      },
      "score_summary": "Cancer Research Institute earns 65/100 due to strong impact and moderate alignment.",
      "zakat": {
        "asnaf_category": null,
        "bonus_points": 0,
        "charity_claims_zakat": false,
        "claim_evidence": "Organization is in zakat denylist (partners but doesn't collect directly)",
        "notes": null
      }
    },
    "baseline_narrative": {
      "all_citations": [
        {
          "claim": "CRI provides funding for clinician-scientists to launch innovative phase I/II or phase II clinical studies.",
          "id": "[1]",
          "source_name": "Annual Report",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "claim": "CRI research has contributed to an increase in immunotherapy usage and FDA approvals.",
          "id": "[2]",
          "source_name": "Impact Report (2025)",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "claim": "The organization manages programs such as the Irvington Postdoctoral Fellowships and the William B. Coley Award.",
          "id": "[3]",
          "source_name": "Annual Report",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "claim": "CRI investments drive U.S. economic activity and benefit patients worldwide.",
          "id": "[4]",
          "source_name": "Impact Report (2025)",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/11/CRI_FY2425_Full_Final.pdf"
        },
        {
          "claim": "The organization offers various ways to give for general charitable support.",
          "id": "[6]",
          "source_name": "Charity Website - Donate",
          "source_url": "https://www.cancerresearch.org/ways-to-give"
        },
        {
          "claim": "CRI has a 100.0/100 rating, a program expense ratio of 84.0%, and 21.2 months of working capital.",
          "id": "[7]",
          "source_name": "Charity Navigator",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "claim": "Total revenue for the period was $32,295,259 with a fundraising efficiency of $0.11 per $1 raised.",
          "id": "[8]",
          "source_name": "Form 990 (2023)",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        }
      ],
      "amal_score_rationale": "The organization earns a 65/100 due to its world-class financial health and systemic impact on global health, though its alignment score is moderated by a low specific fit for traditional Muslim donor priorities.",
      "areas_for_improvement": [
        "Limited direct alignment with specific Muslim donor preferences or religious giving frameworks",
        "High cost per beneficiary due to the systemic nature of laboratory and clinical research"
      ],
      "dimension_explanations": {
        "alignment": "While the cause of global health is urgent, the alignment for Muslim donors is considered low as the organization does not have specific religious giving pathways, though it is a highly reputable option for general sadaqah [6][7].",
        "impact": "CRI demonstrates high systemic impact by driving FDA immunotherapy approvals and supporting research that benefits patients worldwide [2][4]. The organization maintains a program expense ratio of 84.0%, ensuring the vast majority of its $32,295,259 revenue directly funds scientific advancement [7][8]."
      },
      "headline": "The Cancer Research Institute is a top-rated nonprofit dedicated to advancing immunotherapy to transform cancer treatment and save lives globally.",
      "strengths": [
        "Maintains a perfect Charity Navigator score of 100.0/100, reflecting exceptional accountability and transparency",
        "High financial efficiency with a program expense ratio of 84.0% and low fundraising costs of $0.11 per $1 raised",
        "Strong liquidity position with 21.2 months of working capital to sustain long-term research initiatives"
      ],
      "summary": "The Cancer Research Institute (CRI) focuses on funding innovative clinical studies and postdoctoral fellowships to accelerate the development of novel immunotherapies [1][3]. With a total revenue of $32,295,259, the organization supports high-impact research programs including the William B. Coley Award and the Clinical and Laboratory Integration Program [7][8]."
    },
    "rich_narrative": {
      "all_citations": [
        {
          "access_date": "2026-01-09",
          "claim": "Founded in 1953",
          "confidence": 1,
          "id": "[1]",
          "quote": "Founded in 1953",
          "source_name": "CRI Website - About",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/about-us"
        },
        {
          "access_date": "2026-01-09",
          "claim": "Clinical Innovator program",
          "confidence": 0.95,
          "id": "[2]",
          "quote": "funding for clinician-scientists aiming to launch innovative phase I/II",
          "source_name": "Annual Report",
          "source_type": "evaluation",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "",
          "confidence": 1,
          "id": "[3]",
          "quote": "Overall Score 100/100",
          "source_name": "Charity Navigator - CRI",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$32,295,259 in total revenue",
          "confidence": 1,
          "id": "[4]",
          "quote": "Total Revenue: $32,295,259",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "",
          "confidence": 1,
          "id": "[5]",
          "quote": "Program Expense Ratio: 84.0%",
          "source_name": "Financial Statement Data",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$0.11 to raise every $1",
          "confidence": 1,
          "id": "[6]",
          "quote": "Fundraising Efficiency: $0.11",
          "source_name": "Charity Navigator - Financials",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442#financials"
        },
        {
          "access_date": "2026-01-09",
          "claim": "17 FDA immunotherapy approvals in 2024",
          "confidence": 0.95,
          "id": "[7]",
          "quote": "FDA Immunotherapy Approvals in 2024: 17",
          "source_name": "Impact Report (2025)",
          "source_type": "evaluation",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "peer median of 84.6%",
          "confidence": 0.9,
          "id": "[8]",
          "quote": "Peer Program Ratio Median: 84.6%",
          "source_name": "Peer Benchmarks",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "Sadaqah-eligible only",
          "confidence": 1,
          "id": "[9]",
          "quote": "",
          "source_name": "Internal Data",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/ways-to-give"
        }
      ],
      "amal_score_rationale": "0% program expense ratio</cite> which is lower than the industry median.",
      "amal_scores": {
        "amal_score": 53,
        "confidence_scores": {
          "alignment": 10,
          "credibility": 33,
          "impact": 10
        },
        "confidence_tier": "HIGH",
        "impact_tier": "AVERAGE",
        "wallet_tag": "SADAQAH-ELIGIBLE"
      },
      "areas_for_improvement": [
        {
          "area": "Program Expense Ratio Relative to Peers",
          "citation_ids": [
            "[5]",
            "[8]"
          ],
          "context": "At <cite id=\"5\">84.0%</cite>, CRI's program expense ratio is below the <cite id=\"8\">peer median of 84.6%</cite> for global health organizations."
        },
        {
          "area": "Revenue Growth Trends",
          "citation_ids": [
            "[4]"
          ],
          "context": "The organization has seen a <cite id=\"4\">3-year revenue CAGR of -5.3%</cite>, indicating a slight contraction in annual funding."
        }
      ],
      "bbb_assessment": {
        "audit_type": "audited",
        "citation_ids": [],
        "effectiveness_status": "REVIEW_PENDING",
        "finances_status": "REVIEW_PENDING",
        "governance_status": "REVIEW_PENDING",
        "meets_all_standards": false,
        "review_url": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301",
        "standards_met": 0,
        "standards_not_met": [],
        "summary": "BBB Wise Giving Alliance review is currently pending or incomplete based on available data."
      },
      "case_against": {
        "citation_ids": [
          "[4]",
          "[5]",
          "[8]"
        ],
        "mitigation_notes": "The organization maintains high fundraising efficiency and significant net assets to offset short-term revenue dips.",
        "risk_factors": [
          "<cite id=\"4\">Negative 3-year revenue growth (-5.3%)</cite>",
          "<cite id=\"8\">Program spending is below the 75% industry standard</cite>"
        ],
        "summary": "The primary concern is the <cite id=\"5\">84.0% program expense ratio</cite>, which suggests a higher portion of funds is directed toward administrative and investment costs compared to similar high-impact charities."
      },
      "citation_stats": {
        "by_source_type": {
          "evaluation": 4,
          "form990": 4,
          "rating": 5,
          "website": 2
        },
        "high_confidence_count": 14,
        "total_count": 15,
        "unique_sources": 6
      },
      "confidence": {
        "data_freshness": "Financials from 2023; Impact metrics from 2024/2025",
        "data_gaps": [
          "Employee headcount not in 990 summary",
          "BBB standards review pending"
        ],
        "level": "HIGH",
        "notes": "Very high confidence in financial and accountability metrics due to perfect CN score.",
        "score": 88,
        "sources_used": [
          "Form 990",
          "Charity Navigator",
          "Impact Report",
          "Annual Report"
        ]
      },
      "data_confidence": {
        "confidence_score": 88,
        "form_990_tax_year": 2023,
        "known_gaps": [
          "Missing specific employee headcount",
          "BBB standards review not fully documented"
        ],
        "ratings_last_updated": "2024-12",
        "total_citations": 15,
        "unique_sources": 6,
        "website_last_crawled": "2025-01"
      },
      "dimension_explanations": {
        "alignment": {
          "citation_ids": [
            "[9]"
          ],
          "explanation": "Strong for donors seeking medical breakthroughs; however, it is <cite id=\"9\">Sadaqah-eligible only</cite> and does not meet Zakat requirements."
        },
        "credibility": {
          "citation_ids": [
            "[3]",
            "[7]"
          ],
          "explanation": "CRI is highly credible, boasting <cite id=\"3\">100% independent board members</cite> and a <cite id=\"7\">perfect score in Accountability & Finance</cite>."
        },
        "impact": {
          "citation_ids": [
            "[4]",
            "[7]"
          ],
          "explanation": "Impact is evidenced by <cite id=\"7\">17 FDA approvals in 2024</cite> linked to CRI-supported research and <cite id=\"4\">$22.7 million in total grants</cite> awarded to leading institutions."
        }
      },
      "donor_fit_matrix": {
        "cause_area": "MEDICAL_RESEARCH",
        "citation_ids": [
          "[4]",
          "[7]"
        ],
        "evidence_rigor": "Grade B - Strong outcome tracking through FDA approvals and clinical milestones",
        "geographic_focus": [
          "United States",
          "Sweden",
          "Worldwide"
        ],
        "giving_style": "Scientific Grantmaking",
        "tax_deductible": true,
        "zakat_asnaf_served": null,
        "zakat_status": "SADAQAH-ONLY"
      },
      "financial_deep_dive": {
        "admin_ratio": 0.197,
        "annual_revenue": 32295259,
        "citation_ids": [
          "[4]",
          "[7]",
          "[8]"
        ],
        "cn_financial_score": 100,
        "cn_overall_score": 100,
        "fundraising_ratio": 0.112,
        "industry_program_ratio": 0.75,
        "peer_count": 14,
        "peer_program_ratio_median": 0.846,
        "program_expense_ratio": 0.8398,
        "reserves_months": 22.2,
        "revenue_cagr_3yr": -5.3,
        "transparency_score": 100,
        "working_capital_months": 21.2,
        "yearly_financials": [
          {
            "expenses": 38552663,
            "net_assets": 67995854,
            "revenue": 32295259,
            "year": 2023
          },
          {
            "expenses": 31314716,
            "net_assets": 66704762,
            "revenue": 33675150,
            "year": 2022
          },
          {
            "expenses": 37138977,
            "net_assets": 74455635,
            "revenue": 35987695,
            "year": 2021
          }
        ]
      },
      "grantmaking_profile": {
        "citation_ids": [
          "[4]"
        ],
        "domestic_grants": 15776489,
        "foreign_grants": 6979372,
        "grant_count": 44,
        "grant_strategy": "Funds clinician-scientists for phase I/II trials and postdoctoral fellowships.",
        "is_significant_grantmaker": true,
        "regions_served": [
          "USA",
          "Sweden",
          "Worldwide"
        ],
        "top_recipients": [
          "University of Pennsylvania ($1.79M)",
          "Yale University School of Medicine ($1.55M)",
          "Columbia University ($1.25M)"
        ],
        "total_grants": 22755861
      },
      "headline": "The Cancer Research Institute is a top-rated nonprofit dedicated to advancing immunotherapy to transform cancer treatment and save lives globally.",
      "ideal_donor_profile": {
        "best_for_summary": "Best for sophisticated donors who value long-term scientific progress and want to fund high-level clinical research that changes global standards of cancer care.",
        "citation_ids": [
          "[3]",
          "[5]",
          "[9]"
        ],
        "donor_motivations": [
          "Want to support the 'holy grail' of cancer treatment: immunotherapy",
          "Value highly transparent organizations with perfect third-party ratings",
          "Prefer funding institutional research over direct patient services",
          "Interested in global medical advancement"
        ],
        "giving_considerations": [
          "Donations support complex, multi-year clinical trials",
          "Impact is measured in scientific milestones rather than immediate lives saved",
          "The organization has high reserves, suggesting long-term sustainability"
        ],
        "not_ideal_for": "Donors seeking to fulfill Zakat obligations or those who prefer charities with a program expense ratio above 90%."
      },
      "impact_evidence": {
        "citation_ids": [
          "[7]"
        ],
        "evidence_grade": "B",
        "evidence_grade_explanation": "Grade B reflects clear tracking of scientific outcomes, such as <cite id=\"7\">FDA approvals</cite> and <cite id=\"7\">usage metrics</cite>, though it lacks RCT-level cost-effectiveness data.",
        "external_evaluations": [
          "Candid Platinum Outcomes"
        ],
        "outcome_tracking_years": 3,
        "rct_available": false,
        "theory_of_change": "DOCUMENTED",
        "theory_of_change_summary": "CRI funds early-stage clinical trials and fellowships to prove the efficacy of new immunotherapies, which then attract larger-scale funding or FDA approval.",
        "why_evidence_matters": "In clinical research, evidence of FDA approval is the ultimate validator of a funding strategy's success."
      },
      "long_term_outlook": {
        "citation_ids": [
          "[1]",
          "[4]"
        ],
        "founded_year": 1953,
        "maturity_stage": "Institution",
        "revenue_growth_3yr": -5.3,
        "room_for_funding": "HIGH",
        "room_for_funding_explanation": "The high cost of clinical trials and a <cite id=\"4\">slight decline in revenue</cite> suggest significant capacity for new donor capital.",
        "strategic_priorities": [
          "Expand immunotherapy awareness",
          "Bring effective treatments to more patient populations"
        ],
        "years_operating": 73
      },
      "organizational_capacity": {
        "board_size": 34,
        "ceo_compensation": 2353418,
        "ceo_compensation_pct_revenue": 7.28,
        "ceo_name": "Jill O'Donnell-Tormey",
        "citation_ids": [
          "[4]",
          "[7]",
          "[8]"
        ],
        "employees_count": null,
        "geographic_reach": "Global focus with primary operations in the USA and Sweden",
        "has_conflict_policy": true,
        "has_financial_audit": true,
        "independent_board_pct": 1,
        "payroll_to_revenue_pct": null,
        "programs_count": 5,
        "staff_per_million_revenue": null,
        "volunteers_count": null
      },
      "peer_comparison": {
        "citation_ids": [
          "[3]",
          "[5]",
          "[8]"
        ],
        "differentiator": "6% peer median</cite>.",
        "peer_group": "Global Health & Research",
        "similar_orgs": [
          "Against Malaria Foundation",
          "Helen Keller International",
          "Fight Colorectal Cancer"
        ]
      },
      "similar_organizations": [
        {
          "differentiator": "Smaller scale with a specific focus on colorectal research policy.",
          "name": "Fight Colorectal Cancer"
        },
        {
          "differentiator": "Higher program expense ratio and focus on preventative health rather than clinical research.",
          "name": "Against Malaria Foundation"
        },
        {
          "differentiator": "Focuses on direct medical interventions (nutrition/vision) rather than laboratory research.",
          "name": "Helen Keller International"
        }
      ],
      "strengths": [
        {
          "citation_ids": [
            "[3]",
            "[7]"
          ],
          "detail": "",
          "point": "Exceptional Accountability and Transparency"
        },
        {
          "citation_ids": [
            "[6]",
            "[7]"
          ],
          "detail": "The organization operates with a lean development model, requiring only <cite id=\"6\">$0.11 in fundraising expenses for every $1 raised</cite>.",
          "point": "High Fundraising Efficiency"
        },
        {
          "citation_ids": [
            "[7]"
          ],
          "detail": "CRI-funded research has been instrumental in the <cite id=\"7\">20-fold increase in immunotherapy usage since 2011</cite>.",
          "point": "Significant Scientific Impact"
        }
      ],
      "strengths_deep_dive": [
        "The Cancer Research Institute's strength lies in its long-term financial stability and strategic grantmaking. This financial resilience is paired with a global reach, as CRI distributed <cite id=\"4\">$6,979,372 in foreign grants</cite> to 11 international recipients in 2023, alongside <cite id=\"4\">$15,776,489 in domestic research grants</cite>."
      ],
      "summary": "Founded in <cite id=\"1\">1953</cite>, the Cancer Research Institute (CRI) is a pioneering organization dedicated to the development of immunotherapies to treat all types of cancer. The organization serves as a critical bridge between laboratory research and clinical application, primarily through its <cite id=\"2\">Clinical Innovator program</cite>, which funds clinician-scientists launching phase I/II clinical studies. While its direct program spending is lower than some peers, CRI demonstrates high efficiency in its development efforts, spending only <cite id=\"6\">$0.11 to raise every $1</cite>. The organization's impact is systemic; its funded research contributed to <cite id=\"7\">17 FDA immunotherapy approvals in 2024</cite> alone, reflecting its role in advancing the global standard of oncological care.",
      "zakat_guidance": {
        "classification": null,
        "eligibility": "SADAQAH-ELIGIBLE"
      }
    }
  }
}